Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiresistant bacteria in a Scandinavian perspective]

K G Kristinsson1

  • 1Kliniken för mikrobiologi, Landspitalinn, Reykjavik.

Nordisk Medicin
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease.

Vaccine·2022
Same author

Utility of oropharyngeal real-time PCR for S. pneumoniae and H. influenzae for diagnosis of pneumonia in adults.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same author

Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975-2014.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same author

Epidemiology of penicillin-non-susceptible pneumococci in Iceland, 1995-2010.

The Journal of antimicrobial chemotherapy·2013
Same author

Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2010
Same journal

[Nordisk Medicine 1929-1998. Thanks and farewell!].

Nordisk medicin·1999
Same journal

[Scientific fraud and misconduct--need for comprehensive terminology].

Nordisk medicin·1999
Same journal

[Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

Nordisk medicin·1999
Same journal

[Internet in consultation--headed for trouble?].

Nordisk medicin·1999
Same journal

[Interpretation of questionnaires. An translation method problem].

Nordisk medicin·1999
Same journal

[Assessment of patients' health status--review of the literature and assessment methods].

Nordisk medicin·1999
See all related articles

The rise of multiresistant bacteria threatens the antibiotic era, with increasing resistance observed in key pathogens. Urgent, concerted action is needed to combat this growing global health crisis.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • The global increase in bacterial resistance poses a significant threat to modern medicine, potentially signaling the end of the antibiotic era.
  • Rising resistance in key pathogens like Streptococcus pneumoniae, Enterococcus spp., and Staphylococcus aureus is particularly concerning due to a lack of new antimicrobial development.
  • Emerging resistance in Haemophilus influenzae and Neisseria meningitidis presents potential future challenges.

Purpose of the Study:

  • To highlight the escalating global threat of multiresistant bacteria.
  • To underscore the urgent need for antimicrobial stewardship and new drug development.
  • To examine the current status of antimicrobial resistance in Nordic countries.

Main Methods:

Related Experiment Videos

  • Literature review and synthesis of existing data on antimicrobial resistance patterns.
  • Analysis of reported cases of multiresistant bacterial infections globally and in specific regions.
  • Epidemiological surveillance data interpretation.

    • Main Results:

    • Multiresistant bacteria are increasing globally, challenging existing antibiotic treatments.
    • While some Nordic countries have been less affected, multiresistant enterococci are rising, and penicillin-resistant pneumococci are endemic in parts of Sweden.
    • The lack of novel antimicrobial agents exacerbates the crisis.

    Conclusions:

    • The increasing prevalence of multiresistant bacteria necessitates immediate and coordinated global action.
    • Effective strategies must be implemented to preserve the efficacy of current antibiotics and encourage the development of new ones.
    • Continued surveillance and intervention are crucial to mitigate the impact of antimicrobial resistance.